18 related articles for article (PubMed ID: 35289275)
1. Biomarkers in renal cell carcinoma and their targeted therapies: a review.
Gupta S; Kanwar SS
Explor Target Antitumor Ther; 2023; 4(5):941-961. PubMed ID: 37970211
[TBL] [Abstract][Full Text] [Related]
2. Endothelial Delta-like 4 (DLL4) promotes renal cell carcinoma hematogenous metastasis.
Huang QB; Ma X; Li HZ; Ai Q; Liu SW; Zhang Y; Gao Y; Fan Y; Ni D; Wang BJ; Zhang X
Oncotarget; 2014 May; 5(10):3066-75. PubMed ID: 24931473
[TBL] [Abstract][Full Text] [Related]
3. Upregulated
Wang X; Zhang J; Wang Y; Tu M; Wang Y; Shi G
Onco Targets Ther; 2018; 11():1697-1706. PubMed ID: 29618931
[TBL] [Abstract][Full Text] [Related]
4. Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4.
Huang QB; Ma X; Zhang X; Liu SW; Ai Q; Shi TP; Zhang Y; Gao Y; Fan Y; Ni D; Wang BJ; Li HZ; Zheng T
PLoS One; 2013; 8(6):e67294. PubMed ID: 23826258
[TBL] [Abstract][Full Text] [Related]
5. Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma.
Wu F; Wu S; Gou X
Neoplasma; 2018; 65(2):242-252. PubMed ID: 29534586
[TBL] [Abstract][Full Text] [Related]
6. Delta-like ligand 4 (Dll4) predicts the prognosis of clear cell renal cell carcinoma, and anti-Dll4 suppresses tumor growth in vivo.
Hu GH; Liu H; Lai P; Guo ZF; Xu L; Yao XD; Zheng JH; Liu M; Xu YF
Int J Clin Exp Pathol; 2014; 7(5):2143-52. PubMed ID: 24966922
[TBL] [Abstract][Full Text] [Related]
7. Potential biomarkers and the molecular mechanism associated with DLL4 during renal cell carcinoma progression.
Wang X; Zhang J; Wang Y; Wang Y; Yu W; Shi G
Am J Med Sci; 2022 Aug; 364(2):220-228. PubMed ID: 35289275
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
Schanza LM; Seles M; Stotz M; Fosselteder J; Hutterer GC; Pichler M; Stiegelbauer V
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165391
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
